Andrea Witteck
MRSA admission screening in a low prevalence setting - much ado about nothing?
Witteck A, Rettenmund G, Schlegel M. MRSA admission screening in a low prevalence setting - much ado about nothing?. Swiss Med Wkly 2011; 141:w13217.
07.07.2011MRSA admission screening in a low prevalence setting - much ado about nothing?
07.07.2011Swiss Med Wkly 2011; 141:w13217
Witteck Andrea, Rettenmund G, Schlegel Matthias
Hepatitis E Virus Seroprevalence and Chronic Infections in Patients with HIV, Switzerland
Kenfak-Foguena A, Cavassini M, Izpopet J, Abravanel F, Moradpour D, Jost J, Gurter-De La Fuente V, Elzi L, Evison J, Kaiser L, Kovari H, Darling K, Witteck A, Bürgisser P, Schöni-Affolter F, Data Center of the Swiss HIV Cohort Study, Lausanne, Switzerland. Hepatitis E Virus Seroprevalence and Chronic Infections in Patients with HIV, Switzerland. Emerging Infect Dis 2011; 17:1074-8.
01.06.2011Hepatitis E Virus Seroprevalence and Chronic Infections in Patients with HIV, Switzerland
01.06.2011Emerging Infect Dis 2011; 17:1074-8
Kenfak-Foguena Alain, Cavassini Matthais, Izpopet Jacques, Abravanel Florence, Moradpour Darius, Jost Josef, Gurter-De La Fuente Vanina, Elzi Luigia, Evison John-Marc, Kaiser Laurent, Kovari Helen, Darling Katharine E A, Witteck Andrea, Bürgisser Phillippe, Schöni-Affolter Franziska, Data Center of the Swiss HIV Cohort Study, Lausanne, Switzerland
Management of hepatitis C virus (HCV) infection in drug substitution programs
Witteck A, Schmid P, Hensel-Koch K, Thurnheer M, Bruggmann P, Vernazza P. Management of hepatitis C virus (HCV) infection in drug substitution programs. Swiss Med Wkly 2011; 141:w13193.
27.05.2011Management of hepatitis C virus (HCV) infection in drug substitution programs
27.05.2011Swiss Med Wkly 2011; 141:w13193
Witteck Andrea, Schmid Patrick, Hensel-Koch K, Thurnheer M C, Bruggmann P, Vernazza Pietro
Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study
Rauch A, Hirschel B, Malinverni R, Moradpour D, Mullhaupt B, Witteck A, Beckmann J, Berg T, Bergmann S, Negro F, Telenti A, Bochud P, Swiss Hepatitis C Cohort Study, Heim M, Günthard H, Furrer H, Kutalik Z, Descombes P, Cai T, di Iulio J, Mueller T, Bochud M, Battegay M, Bernasconi E, Borovicka J, Colombo S, Cerny A, Dufour J, Swiss HIV Cohort Study. Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study. Gastroenterology 2010; 138:1338-45, 1345.e1-7.
11.01.2010Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study
11.01.2010Gastroenterology 2010; 138:1338-45, 1345.e1-7
Rauch Andri, Hirschel Bernard, Malinverni Raffaele, Moradpour Darius, Mullhaupt Beat, Witteck Andrea, Beckmann Jacques S, Berg Thomas, Bergmann Sven, Negro Francesco, Telenti Amalio, Bochud Pierre-Yves, Swiss Hepatitis C Cohort Study, Heim Markus, Günthard Huldrych F, Furrer Hansjakob, Kutalik Zoltán, Descombes Patrick, Cai Tao, di Iulio Julia, Mueller Tobias, Bochud Murielle, Battegay Manuel, Bernasconi Enos, Borovicka Jan, Colombo Sara, Cerny Andreas, Dufour Jean-François, Swiss HIV Cohort Study
Contribution of genome-wide significant single-nucleotide polymorphisms and antiretroviral therapy to dyslipidemia in HIV-infected individuals: a longitudinal study
Rotger M, Tarr P, Telenti A, Ledergerber B, Weber R, Witteck A, Furrer H, Hirschel B, Battegay M, Bernasconi E, Cavassini M, Martinez R, Taffé P, Bayard C, Swiss HIV Cohort Study. Contribution of genome-wide significant single-nucleotide polymorphisms and antiretroviral therapy to dyslipidemia in HIV-infected individuals: a longitudinal study. Circulation. Cardiovascular genetics 2009; 2:621-8.
01.12.2009Contribution of genome-wide significant single-nucleotide polymorphisms and antiretroviral therapy to dyslipidemia in HIV-infected individuals: a longitudinal study
01.12.2009Circulation. Cardiovascular genetics 2009; 2:621-8
Rotger Margalida, Tarr Philip E, Telenti Amalio, Ledergerber Bruno, Weber Rainer, Witteck Andrea, Furrer Hansjakob, Hirschel Bernard, Battegay Manuel, Bernasconi Enos, Cavassini Matthias, Martinez Raquel, Taffé Patrick, Bayard Cornelia, Swiss HIV Cohort Study
Unusually high HIV infectiousness in an HIV-, HCV- and HSV-2-coinfected heterosexual man
Witteck A, Yerly S, Vernazza P. Unusually high HIV infectiousness in an HIV-, HCV- and HSV-2-coinfected heterosexual man. Swiss medical weekly : official journal of the Swiss Society of Infectious Diseases, the Swiss Society of Internal Medicine, the Swiss Society of Pneumology 2009; 139:207-9.
04.04.2009Unusually high HIV infectiousness in an HIV-, HCV- and HSV-2-coinfected heterosexual man
04.04.2009Swiss medical weekly : official journal of the Swiss Society of Infectious Diseases, the Swiss Society of Internal Medicine, the Swiss Society of Pneumology 2009; 139:207-9
Witteck Andrea, Yerly Sabine, Vernazza Pietro
Delayed diagnosis of atypical mycobacterial skin and soft tissue infections in non-immunocompromized hosts
Witteck A, Öhlschlegel C, Boggian K. Delayed diagnosis of atypical mycobacterial skin and soft tissue infections in non-immunocompromized hosts. Scand J Infect Dis 2008; 40:877-80.
01.01.2008Delayed diagnosis of atypical mycobacterial skin and soft tissue infections in non-immunocompromized hosts
01.01.2008Scand J Infect Dis 2008; 40:877-80
Witteck Andrea, Öhlschlegel Christian, Boggian Katia
Rho protein-mediated changes in the structure of the actin cytoskeleton regulate human inducible NO synthase gene expression
Witteck A, Yao Y, Fechir M, Förstermann U, Kleinert H. Rho protein-mediated changes in the structure of the actin cytoskeleton regulate human inducible NO synthase gene expression. Experimental cell research 2003; 287:106-15.
01.07.2003Rho protein-mediated changes in the structure of the actin cytoskeleton regulate human inducible NO synthase gene expression
01.07.2003Experimental cell research 2003; 287:106-15
Witteck Andrea, Yao Ying, Fechir Marcel, Förstermann Ulrich, Kleinert Hartmut
Inhibition of small G proteins of the rho family by statins or clostridium difficile toxin B enhances cytokine-mediated induction of NO synthase II
Hausding M, Witteck A, Rodriguez-Pascual F, von Eichel-Streiber C, Förstermann U, Kleinert H. Inhibition of small G proteins of the rho family by statins or clostridium difficile toxin B enhances cytokine-mediated induction of NO synthase II. British journal of pharmacology 2000; 131:553-61.
01.10.2000Inhibition of small G proteins of the rho family by statins or clostridium difficile toxin B enhances cytokine-mediated induction of NO synthase II
01.10.2000British journal of pharmacology 2000; 131:553-61
Hausding M, Witteck Andrea, Rodriguez-Pascual F, von Eichel-Streiber C, Förstermann U, Kleinert H